计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
F125720-200mg |
200mg |
期货 ![]() |
| |
F125720-250mg |
250mg |
现货 ![]() |
| |
F125720-1g |
1g |
现货 ![]() |
| |
F125720-5g |
5g |
现货 ![]() |
| |
F125720-10g |
10g |
期货 ![]() |
| |
F125720-25g |
25g |
现货 ![]() |
| |
F125720-100g |
100g |
现货 ![]() |
|
别名 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-1,3-噻唑-5-羧酸 |
---|---|
英文别名 | BC164443 | C16H16N2O3S | FEBUXOSTAT (MART.) | Febuxostat [USAN:INN:BAN] | HMS3655C03 | AC-425 | Q417296 | CCG-213303 | DTXSID8048650 | 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid | Febuxostat | FEBUXOSTAT [VANDF] | 2-(3-Cyano- |
规格或纯度 | Moligand™, ≥98% |
英文名称 | Febuxostat |
生化机理 | 非布索坦是一种强效的非嘌呤黄嘌呤氧化酶抑制剂。非布索司他是一种强效的非嘌呤黄嘌呤氧化酶抑制剂(K i = 0.6 nM)。抑制黄嘌呤脱氢酶。降低尿酸和 ROS 水平。在体内具有抗高尿酸血症、抗缺血、保护心脏和肾脏的作用 |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | 黄嘌呤脱氢酶抑制剂 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
Febuxostat (非布司他; TEI 6720;TMX 67 ) 是选择性黄嘌呤氧化酶(XO)抑制剂,Ki为0.6 nM。An inhibitor xanthine oxidase and xanthine dehydrogenase Product Description: Febuxostat(TEI 6720;TMX 67 ) is selective xanthine oxidase inhibitor with Ki of 0.6 nM.An inhibitor xanthine oxidase and xanthine dehydrogenase. Febuxostat is a potent, non-purine compound, which inhibits the expression of cytokines/chemokines. It has also been reported to inhibit LPS-induced TNF-α, VCAM-1, MMP9 and MCP-1 expression. |
ALogP | 3.9 |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504757026 |
---|---|
EC号 | 682-158-6 |
分子类型 | 小分子 |
IUPAC Name | 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
INCHI | InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) |
InChi Key | BQSJTQLCZDPROO-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O |
Isomeric SMILES | CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O |
关联CAS | 144060-53-7 |
PubChem CID | 134018 |
NSC Number | 758874 |
MeSH Entry Terms | 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid;6720, TEI;febuxostat;TEI 6720;TEI-6720;TEI6720;uloric |
分子量 | 316.38 |
溶解性 | DMSO 63 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
---|---|
熔点 | 209 °C |
分子量 | 316.400 g/mol |
XLogP3 | 3.900 |
氢键供体数Hydrogen Bond Donor Count | 1 |
氢键受体数Hydrogen Bond Acceptor Count | 6 |
可旋转键计数Rotatable Bond Count | 5 |
精确质量Exact Mass | 316.088 Da |
单同位素质量Monoisotopic Mass | 316.088 Da |
拓扑极表面积Topological Polar Surface Area | 111.000 Ų |
重原子数Heavy Atom Count | 22 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 448.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Purity(HPLC) | 98-100(%) |
---|---|
Melting point | 207-211(℃) |
Appearance(F125720) | White to Off-White Solid, Powder, or Crystals |
Proton NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 25-04-18 | F125720 |
![]() |
分析证书 | 25-03-05 | F125720 |
![]() |
分析证书 | 25-01-13 | F125720 |
![]() |
分析证书 | 24-06-17 | F125720 |
![]() |
分析证书 | 24-06-17 | F125720 |
![]() |
分析证书 | 24-06-17 | F125720 |
![]() |
分析证书 | 24-06-17 | F125720 |
![]() |
分析证书 | 24-06-17 | F125720 |
![]() |
分析证书 | 24-06-12 | F125720 |
![]() |
分析证书 | 24-06-12 | F125720 |
![]() |
分析证书 | 23-09-15 | F125720 |
![]() |
分析证书 | 23-09-15 | F125720 |
![]() |
分析证书 | 23-09-15 | F125720 |
![]() |
分析证书 | 22-05-06 | F125720 |
![]() |
分析证书 | 22-01-27 | F125720 |
1. Zean Zhao, Jian Luo, Hui Liao, Fengxin Zheng, Xinhua Chen, Jiajun Luo, Yongjun Chen, Kunlu Zhao, Shuqin Zhang, Jinhong Tian, Ting Wu, Yongmei Li, Lu Li, Yang Yang, Cuiting Lin, Qun Zhang, Yuanxin Tian, Jianxin Pang. (2023) Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity. BIOORGANIC CHEMISTRY, 133 (106405). [PMID:36753966] [10.1016/j.bioorg.2023.106405] |
2. Yan Liu, Chenggang Han, Tao Lu, Yi Liu, Hao Chen, Can Yang, Yanbei Tu, Yanfang Li. (2021) Investigation of the interaction between Chrysoeriol and xanthine oxidase using computational and in vitro approaches. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 190 (463). [PMID:34506859] [10.1016/j.ijbiomac.2021.08.231] |
1. Zean Zhao, Jian Luo, Hui Liao, Fengxin Zheng, Xinhua Chen, Jiajun Luo, Yongjun Chen, Kunlu Zhao, Shuqin Zhang, Jinhong Tian, Ting Wu, Yongmei Li, Lu Li, Yang Yang, Cuiting Lin, Qun Zhang, Yuanxin Tian, Jianxin Pang. (2023) Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity. BIOORGANIC CHEMISTRY, 133 (106405). [PMID:36753966] [10.1016/j.bioorg.2023.106405] |
2. Yan Liu, Chenggang Han, Tao Lu, Yi Liu, Hao Chen, Can Yang, Yanbei Tu, Yanfang Li. (2021) Investigation of the interaction between Chrysoeriol and xanthine oxidase using computational and in vitro approaches. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 190 (463). [PMID:34506859] [10.1016/j.ijbiomac.2021.08.231] |